PPT-Drug-eluting coronary stent market overview

Zach Eddy Category Advisor 2 What are drugeluting coronary stents Design Expandable wire mesh tube Coated with an antiproliferative drug Premounted on a balloon catheter delivery system Function. resténose. . intra-stent. au ballon actif. Peeper. Pre-procedure. Post-procedure. 6-month. In-stent. Reference. vessel diameter. 2.84 ± 0.39mm. 2.86 ± 0.39mm. 2.82 ± 0.38mm. Minimum lumen diameter. Dalby. , Munich, ESC2008. Update about the OCT data of the . Translumina. DES and competitors. A . Randomised. . optical. . coherence. . tomography. . study. . to. . determine. 90 . day. . stent. January 15. th. , 2016. 10h30. What is/are the best antithrombotic treatment(s) in case of stent thrombosis?. A. ). . 75mg . of . clopidogrel. B). 150mg . of . clopidogrel. C). 90mg x 2 . of . ticagrelor. , . and Bio-. Absorbables. . John Wainwright, Ph.D.. Sr. R&D . Manager, Medtronic plc. WLNC 06/08/15. Some of the technologies/devices discussed in this talk are not approved in the US . Reasons for Coatings and Surface Modifications. Prepared by Radcliffe Cardiology. 21 November2016. Abbreviations. CABG: . coronary artery bypass grafting. CAD: . coronary artery disease. FFR: . fractional flow reserve. ISR. : in-stent restenosis. IVUS. Dr. Ahmed . Refaey. MBBCh. , MS, FRCR. Format of the lecture. Normal anatomy of coronary arteries. MSCT coronary . angio. Clinical application of CTA. Illustrated cases. Coronary arteries anatomy. LCA “ left coronary artery “. coronary intervention – . summary of key articles. Prepared by Radcliffe Cardiology. 21 November2016. Abbreviations. CABG: . coronary artery bypass grafting. CAD: . coronary artery disease. FFR: . fractional flow reserve. , . and Bio-. Absorbables. . John Wainwright, Ph.D.. Sr. R&D . Manager, Medtronic plc. WLNC 06/08/15. Some of the technologies/devices discussed in this talk are not approved in the US . Reasons for Coatings and Surface Modifications. Gunjan. . Gholkar. MD. Metro Heart and Vascular. Objectives. Show lots of pretty pictures. Raise awareness of current indications and clinical scenarios for which to consider CT . angiography. Interpretation of reports. Sunil V. Rao MD FSCAI. Duke University Health System. Durham VA Health System. Disclosures . Institutional research funding. Svelte Inc. Shockwave Medical. Bayer . No consulting RWI . Thanks to Ajay . GP . Superclinic@Midland. Railway Workshops Heart Week Event. Dr. . Chris . Judkins. . MBBS . MClinRes. FRACP. Interventional Cardiologist. WA Cardiology. Fiona Stanley Hospital. www.perthheart.com. Bioresorbable. Polymer-Based Drug-Eluting Stent in an All-Comers Patient Population. Lisette Okkels Jensen, Michael . Maeng. , Bent . Raungaard. , Johnny . Kahlert. , Julia Ellert, Lars . Jakobsen. , . Lyndon C. Box, MD FSCAI. West Valley Cardiology, Caldwell ID. On behalf of the authors, SCAI Executive Committee and the SCAI Government Relations Committee. Disclosures. NONE. Why?. Centers for Medicaid and Medicare Services, . Present and Future. Taehoon. . Ahn. , MD, PhD, FSCAI, FACC. Gachon. University Gil Medical Center . Incheon, South Korea. JCR2016. Conflict of interest: Nothing to report. Disclosure. Current situation of Korea made drug-eluting stents in Korea .